The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities

被引:0
作者
Umar Mehraj
Rais A. Ganai
Muzafar A. Macha
Abid Hamid
Mohammed A. Zargar
Ajaz A. Bhat
Mohd Wasim Nasser
Mohammad Haris
Surinder K. Batra
Bader Alshehri
Raid Saleem Al-Baradie
Manzoor A. Mir
Nissar Ahmad Wani
机构
[1] University of Kashmir,Department of Bioresources
[2] Islamic University of Science & Technology ,Watson
[3] Central University of Kashmir,Crick Centre for Molecular Medicine
[4] Sidra Medicine,Department of Biotechnology, School of Life Sciences
[5] University of Nebraska Medical Center,Translational Medicine, Research Branch
[6] Qatar University,Department of Biochemistry and Molecular Biology
[7] Eppley Institute for Research in Cancer and Allied Diseases,Laboratory of Animal Research
[8] University of Nebraska,Buffett Cancer Center
[9] University of Nebraska Medical Center,Department of Medical Laboratory Sciences, College of Applied Medical Sciences
[10] Majmaah University,undefined
来源
Cellular Oncology | 2021年 / 44卷
关键词
Breast cancer; Tumor microenvironment; Targeted therapeutics; Cancer-associated fibroblasts; Tumor-associated macrophages; Immunotherapy; Cancer stemness;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1209 / 1229
页数:20
相关论文
共 622 条
[41]  
Jonkers J(2020)Pathological crosstalk between metastatic breast cancer cells and the bone microenvironment Biomolecules 10 10123-106
[42]  
Avgustinova A(2007)Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts Can. Res. 67 165-52
[43]  
Lappano R(2011)Oskarsson T, Vanharanta S, et al, A CXCL1 paracrine network links cancer chemoresistance and metastasis Cell 150 636-91
[44]  
Rigiracciolo DC(2005)Clements VK, Ostrand-Rosenberg S, Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease J. Immunol. 174 6713-406
[45]  
Belfiore A(2005)Kapoor V, Jassar AS, Kaiser LR, Albelda SM, Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity Clin Cancer res 11 35-584
[46]  
Maggiolini M(2009)Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche Cancer Cell 15 R79-10
[47]  
De Francesco EM(2013)A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model Breast cancer research : BCR 15 3156-55
[48]  
Soon PS(2016)Myeloid-derived suppressor cells endow stem-like qualities to breast cancer cells through IL6/STAT3 and NO/NOTCH cross-talk signaling Can. Res. 76 189-575
[49]  
Kim E(2007)Rose DP, Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression Endocr. Relat. Cancer 14 102-539
[50]  
Pon CK(2011)Cancer-associated adipocytes promotes breast tumor radioresistance Biochem. Biophys. Res. Commun. 411 45-E98